E Fund Management Co., Ltd. Exact Sciences Corp Transaction History
E Fund Management Co., Ltd.
- $1.97 Billion
- Q4 2024
A detailed history of E Fund Management Co., Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 15,106 shares of EXAS stock, worth $774,635. This represents 0.04% of its overall portfolio holdings.
Number of Shares
15,106
Previous 16,576
8.87%
Holding current value
$774,635
Previous $1.13 Million
24.82%
% of portfolio
0.04%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$899 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$873 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$619 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$618 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$320 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.07B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...